101922-3
Eculizumab Monitoring Panel
Active
74520-8 Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
Fully-Specified Name
- Component
- Complement alternate pathway AH50 actual/normal
- Property
- RelACnc
- Time
- Pt
- System
- Ser
- Scale
- Qn
- Method
- IA
Additional Names
- Short Name
- AH50 Act/Nor Ser IA
- Display Name
- Complement alternate pathway AH50 actual/normal IA (S) [Rel units/Vol]
- Consumer Name Alpha Get Info
- Complement Alternate Pathway AH50 actual/normal, Blood
Basic Attributes
- Class
- HEM/BC
- Type
- Laboratory
- First Released
- Version 2.48
- Last Updated
- Version 2.73
- Change Reason
- Updated term to align with existing complement activity terms and clarify that findings are based on actual/normal results.; The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016.
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 7463
Member of these Panels
LOINC | Long Common Name |
---|---|
74519-0 | Complement activity panel - Serum |
101922-3 | Eculizumab Monitoring Panel |
101923-1 | Ravulizumab Monitoring Panel |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-ES | Spanish (Spain) | Complemento total vía alternativa AH50 actual/normal: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Complementar la vía alternativa AH50 real / normal: |
et-EE | Estonian (Estonia) | Komplemendi alternatiivse tee aktiivsus AH50 tegelik/normaalne: Synonyms: Juhuslik Kvantitatiivne Seerum Suhteline kokkuleppeline kontsentratsioon |
fr-CA | French (Canada) | Complément voie alterne AH50, Mesuré/normal: |
fr-BE | French (Belgium) | Complément voie alterne AP50 Mesuré/normal: Synonyms: Mesuré/normal |
fr-FR | French (France) | Complément alternative pathway AH50 Patient (%): |
it-IT | Italian (Italy) | Complemento totale, via alternativa AH50 effettivo/normale: Synonyms: Concentrazine Arbitraria Relativa Ematologia (coagulazione) conta differenziale Immunoassay Punto nel tempo (episodio) Siero Via alternativa AH50 del complemento totale |
nl-NL | Dutch (Netherlands) | complement totaal alternatieve route AH50 gemeten/normaal: Synonyms: gemeten/normaal IA |
pt-BR | Portuguese (Brazil) | Complemento funcional atividade caminho alternativo: |
ru-RU | Russian (Russian Federation) | Комплемент общий альтернативный путь AH50 актуальный/нормальный: Synonyms: Количественный Относительная произвольная концентрация Сыворотка Точка во времени; |
tr-TR | Turkish (Turkey) | Kompleman total alternatif yol AH50 gerçek/normal: Synonyms: İmmünölçüm, immünoassay |
zh-CN | Chinese (China) | 补体备用途径活性 AH50 实际的/正常的: Synonyms: 免疫测定; |
Example Units
Unit | Source |
---|---|
% | Example UCUM Units |
90240-3 Eculizumab [Mass/volume] in Serum
Part Descriptions
LP268095-9 Eculizumab
Eculizumab is monoclonal antibody that binds to the C5 complement component and is used to treat atypical hemolytic uremic syndrome (aHUS). aHUS is characterized by hemolytic anemia that leads to the presence of schistocytes, thrombocytopenia, renal damage, and other organ system impairment. aHUS is caused by a rare genetic mutation that interferes with the regulation of the complement system and leads to thrombotic microangiopathy (TMA). Prior to the development of eculizumab, the only treatment for aHUS was plasmapheresis, which did not stop progressive organ impairment. Eculizumab is an extremely expensive but effective therapy against aHUS and provides good outcomes and improved quality of life for patients with aHUS. Eculizumab has also been found to increase the possibility for the repair of renal damage. PMID: 27766045Measurement of eculizumab in serum is used for monitoring and therapy optimization.
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Eculizumab
- Property
- MCnc
- Time
- Pt
- System
- Ser
- Scale
- Qn
- Method
Additional Names
- Short Name
- Eculizumab Ser-mCnc
- Display Name
- Eculizumab (S) [Mass/Vol]
- Consumer Name Alpha Get Info
- Eculizumab, Blood
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.65
- Last Updated
- Version 2.65
- Order vs. Observation
- Both
Member of these Panels
LOINC | Long Common Name |
---|---|
101922-3 | Eculizumab Monitoring Panel |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Eculizumab: |
es-ES | Spanish (Spain) | Eculizumab: Synonyms: Cuantitativo |
fr-FR | French (France) | Éculizumab: |
it-IT | Italian (Italy) | Eculizumab: Synonyms: Concentrazione di Massa Livelli farmacologici e tossicologia Punto nel tempo (episodio) Siero |
zh-CN | Chinese (China) | 依库珠单抗: Synonyms: 依库组单抗; |
Example Units
Unit | Source |
---|---|
ug/mL | Example UCUM Units |